文献速递垂体与肾上腺疾病

TBC1D32功能缺失变异导致综合征性垂体功能减退

Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

在两个家系中发现TBC1D32双等位基因功能缺失变异与综合征性垂体功能减退相关:芬兰家系两同胞携带复合杂合变异,表现为全垂体功能减退、前叶垂体缺如及轻度颅面畸形;巴基斯坦家系先证者携带已知致病性纯合剪接位点变异,表现为生长激素缺乏、前叶垂体发育不良及发育迟缓。TBC1D32在发育中的下丘脑、Rathke囊及后脑区域表达,并与纤毛组装、Shh信号及脑发育相关蛋白相互作用,机制可能为Shh信号通路受损。

要点

  • TBC1D32双等位基因功能缺失变异可导致综合征性垂体功能减退。
  • 芬兰家系两同胞携带复合杂合变异c.1165_1166dup与c.2151del,表现为全垂体功能减退和前叶垂体缺如。
  • 巴基斯坦家系先证者携带纯合剪接位点变异c.1372+1G>A,表现为生长激素缺乏和前叶垂体发育不良。

核心结论

  • TBC1D32双等位基因变异是综合征性垂体功能减退的遗传基础,其机制可能为Shh信号通路受损。

研究设计与样本

  • 研究纳入一个芬兰家系(两同胞)和一个巴基斯坦家系(先证者及同一家系终止妊娠胎儿),采用全基因组测序、人胎儿脑组织原位杂交及HEK细胞蛋白相互作用与质谱分析。

主要发现

  • 芬兰家系两同胞携带TBC1D32复合杂合功能缺失变异c.1165_1166dup p.(Gln390Phefs*32)和c.2151del p.(Lys717Asnfs*29),表现为全垂体功能减退、前叶垂体缺如及轻度颅面畸形。
  • 巴基斯坦家系先证者携带已知致病性纯合TBC1D32剪接位点变异c.1372+1G>A p.(Arg411_Gly458del),表现为生长激素缺乏、前叶垂体发育不良及发育迟缓;同一家系终止妊娠胎儿携带相同变异,有唇裂及部分肠旋转不良。
  • TBC1D32在发育中的下丘脑、Rathke囊及后脑区域表达,并与纤毛组装、Shh信号及脑发育相关蛋白相互作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Congenital pituitary hormone deficiencies with syndromic phenotypes and/or familial occurrence suggest genetic hypopituitarism; however, in many such patients the underlying molecular basis of the disease remains unknown. OBJECTIVE: To describe patients with syndromic hypopituitarism due to biallelic loss-of-function variants in TBC1D32, a gene implicated in Sonic Hedgehog (Shh) signaling. SETTING: Referral center. PATIENTS: A Finnish family of 2 siblings with panhypopituitarism, absent anterior pituitary, and mild craniofacial dysmorphism, and a Pakistani family with a proband with growth hormone deficiency, anterior pituitary hypoplasia, and developmental delay. INTERVENTIONS: The patients were investigated by whole genome sequencing. Expression profiling of TBC1D32 in human fetal brain was performed through in situ hybridization. Stable and dynamic protein-protein interaction partners of TBC1D32 were investigated in HEK cells followed by mass spectrometry analyses. MAIN OUTCOME MEASURES: Genetic and phenotypic features of patients with biallelic loss-of-function mutations in TBC1D32. RESULTS: The Finnish patients harboured compound heterozygous loss-of-function variants (c.1165_1166dup p.(Gln390Phefs*32) and c.2151del p.(Lys717Asnfs*29)) in TBC1D32; the Pakistani proband carried a known pathogenic homozygous TBC1D32 splice-site variant c.1372 + 1G > A p.(Arg411_Gly458del), as did a fetus with a cleft lip and partial intestinal malrotation from a terminated pregnancy within the same pedigree. TBC1D32 was expressed in the developing hypothalamus, Rathke's pouch, and areas of the hindbrain. TBC1D32 interacted with proteins implicated in cilium assembly, Shh signaling, and brain development. CONCLUSIONS: Biallelic TBC1D32 variants underlie syndromic hypopituitarism, and the underlying mechanism may be via disrupted Shh signaling.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hietamäki J, Gregory LC, Ayoub S, et al. Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism. J Clin Endocrinol Metab. 2020. PMID: 32060556. doi:10.1210/clinem/dgaa078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。